Home

assumere strafare strano federica montagnese Industrializzare magro Impegno

A look back at Myology 2022 | AFM Téléthon
A look back at Myology 2022 | AFM Téléthon

Publication Highlights - WMS
Publication Highlights - WMS

Federica Montagnese, Dr. med. - Editorial Board - Neuromuscular Disorders -  Journal - Elsevier
Federica Montagnese, Dr. med. - Editorial Board - Neuromuscular Disorders - Journal - Elsevier

2 "Federica Montagnese" profiles | LinkedIn
2 "Federica Montagnese" profiles | LinkedIn

Federica Montagnese - I.I.S. Erasmo da Rotterdam di Nichelino - Torino,  Piemonte, Italia | LinkedIn
Federica Montagnese - I.I.S. Erasmo da Rotterdam di Nichelino - Torino, Piemonte, Italia | LinkedIn

Publication Highlights - WMS
Publication Highlights - WMS

Il Top Management di Intesa Sanpaolo Innovation Center
Il Top Management di Intesa Sanpaolo Innovation Center

Muscle hyperexcitability and cramps – European Reference Network – EURO-NMD
Muscle hyperexcitability and cramps – European Reference Network – EURO-NMD

PDF) Evaluating the diagnostic utility of new line immunoassays for  myositis antibodies in clinical practice: a retrospective study
PDF) Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study

federica montagnese | Flickr
federica montagnese | Flickr

Gestione - DM patient registry for Germany and Switzerland
Gestione - DM patient registry for Germany and Switzerland

Publication Highlight: Distinctive features of LRP12-oculopharyngeal  muscular dystrophy - WMS
Publication Highlight: Distinctive features of LRP12-oculopharyngeal muscular dystrophy - WMS

federica montagnese | Flickr
federica montagnese | Flickr

Federica Montagnese (@femontagnese) / Twitter
Federica Montagnese (@femontagnese) / Twitter

🎶🎧💓 Chiudi gli... - Centro Culturale "Amici della Musica" | Facebook
🎶🎧💓 Chiudi gli... - Centro Culturale "Amici della Musica" | Facebook

PDF) Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2
PDF) Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2

Salvatore Montagnese - Milano | Profilo professionale | LinkedIn
Salvatore Montagnese - Milano | Profilo professionale | LinkedIn

Federica Montagnese - Specializzanda in Neurologia - AOU Policlinico G  Martino | LinkedIn
Federica Montagnese - Specializzanda in Neurologia - AOU Policlinico G Martino | LinkedIn

Dott.ssa Antonella Montagnese - Cosmesidoc
Dott.ssa Antonella Montagnese - Cosmesidoc

Federica Montagnese, Dr. med. - Editorial Board - Neuromuscular Disorders -  Journal - Elsevier
Federica Montagnese, Dr. med. - Editorial Board - Neuromuscular Disorders - Journal - Elsevier

Concetta MONTAGNESE | Researcher | BSc PhD | Istituto Nazionale Tumori  "Fondazione Pascale", Naples | IRCCS | SC Epidemiologia e Biostatistica |  Research profile
Concetta MONTAGNESE | Researcher | BSc PhD | Istituto Nazionale Tumori "Fondazione Pascale", Naples | IRCCS | SC Epidemiologia e Biostatistica | Research profile

Fabrizio MONTAGNESE | DH Multidisciplinary | UOC Medicina Interna |  Research profile
Fabrizio MONTAGNESE | DH Multidisciplinary | UOC Medicina Interna | Research profile

100+ "Montagnese" profiles | LinkedIn
100+ "Montagnese" profiles | LinkedIn

Alessandro Montagnese - Libraio - Galleria del Libro S.A.S. | LinkedIn
Alessandro Montagnese - Libraio - Galleria del Libro S.A.S. | LinkedIn

PDF) Intracranial arterial abnormalities in patients with late onset Pompe  disease
PDF) Intracranial arterial abnormalities in patients with late onset Pompe disease

300+ profili “Montagnese” | LinkedIn
300+ profili “Montagnese” | LinkedIn

100+ "Montagnese" profiles | LinkedIn
100+ "Montagnese" profiles | LinkedIn

federica montagnese | Flickr
federica montagnese | Flickr